Pathological dynamics of activated microglia following medial forebrain bundle transection

GLIA

Volumn 53, Issue 1, 2006, Pages 92-102

  Cho, Byung P ^a,b   Song, Dae Y ^b   Sugama, Shuei ^a,c   Shin, Dong H ^a,d   Shimizu, Yoshinori ^a   Kim, Sung S ^a,e   Kim, Yoon S ^a   Joh, Tong H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Yonsei University Wonju College of Medicine   (South Korea)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d Keimyung University   (South Korea)

^e Kangwon National University   (South Korea)

Author keywords

Axotomy; Dopaminergic neuron; ED1; MHC II; Migration; Parkinson's disease; Phagocytosis

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL LOSS; CELL MIGRATION; CONTROLLED STUDY; DENDRITE; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MEDIAL FOREBRAIN BUNDLE; MICROGLIA; MORPHOMETRICS; NERVE FIBER TRANSECTION; NONHUMAN; PARKINSON DISEASE; PERIKARYON; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; SUBSTANTIA NIGRA;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; DENERVATION; DISEASE MODELS, ANIMAL; DOPAMINE; ECTODYSPLASINS; EFFERENT PATHWAYS; GLIOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOHISTOCHEMISTRY; MALE; MEDIAL FOREBRAIN BUNDLE; MEMBRANE PROTEINS; MICROGLIA; NERVE DEGENERATION; NEURONS; PARKINSON DISEASE; PHAGOCYTOSIS; PHENOTYPE; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; TUMOR NECROSIS FACTORS;

EID: 30444435621     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20265     Document Type: Article

References (74)

1. Akiyama H, Tooyama I, Kondo H, Ikeda K, Kimura H, McGeer EG, McGeer PL. 1994. Early response of brain resident microglia to kainic acid-induced hippocampal lesions. Brain Res 635:257-268.
2. Amat JA, Ishiguro H, Nakamura K, Norton WT. 1996. Phenotypic diversity and kinetics of proliferating microglia and astrocytes following cortical stab wounds. Glia 16:368-382.
3. Banati RB, Daniel SE, Blunt SB. 1998. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov Disord 13:221-227.
4. Bauer J, Sminia T, Wouterlood FG, Dijkstra CD. 1994. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neurosci Res 38:365-375.
5. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F. 1995. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373:339-341.
6. Blinzinger K, Kreutzberg G. 1968. Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z Zellforsch Mikr Anat 85:145-157.
7. Brecknell JE, Dunnett SB, Fawcett JW. 1995. A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle. Neuroscience 64:219-227.
8. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, Lee SC. 1994. Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 16:152-161.
9. Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE. 1983. Pathological changes in the nucleus basalis of Meynert in Alzheimer's and Parkinson's disease. J Neurol Sci 54:277-289.
10. Casals J, Elizan TS, Yahr WH. 1998. Postencephalitic parkinsonism - a review. J Neural Transm 105:645-676.
11. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149:2736-2741.
12. Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ. 1985. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in the rhesus monkey. Life Sci 80:213-218.
13. Cho BP, Sugama S, Shin DH, DeGiorgio LA, Kim SS, Kim YS, Lim SY, Park KC, Volpe BT, Cho S, Job TH. 2003. Microglial phagocytosis of dopamine neurons at early phases of apoptosis. Cell Mol Neurobiol 23:551-560.
14. Czlonkowska A, Kohutnicka M, Kurkowska-Jastrzebska I, Czlonkowski A. 1996. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration 5:137-143.
15. Damoiseaux JG, Dopp EA, Calame W, Chao D, MacPherson GG, Dijkatra CD. 1994. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83:140-147.
16. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83.
17. Factor SA, Sanchez-Ramos J, Weiner WJ. 1988. Trauma as an etiology of parkinsonism: a historical review of the concept. Mov Disord 3:30-36.
18. Forno LS. 1996. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259-272.
19. Forno LS, DeLanney LE, Irwin I, Langston JW, Ricaurte GA. 1986. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol 20:449-455.
20. Forno LS, DeLanne LE, Irwin I, Di Monte D, Langsten JW. 1992. Astrocytes and Parkinson's disease. Prog Brain Res 94:429-436.
21. Francis JW, Von Visger J, Markelonis GJ, Oh TH. 1995. Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6- tetrahydropiridine in mouse striatum. Neurotoxicol Teratol 17:7-12.
22. Frank M, Wolburg H. 1996. Cellular reactions at the lesion site after crushing of the rat optic nerve. Glia 16:227-240.
23. Freyaldenhoven TE, Ali SF, Schmued LC. 1997. Systemic administration of MPTP induces thalamic neuronal degeneration in mice. Brain Res 759:9-17.
24. Gilad G, Reis DJ. 1978. Reversible reduction of tyrosine hydroxylase enzyme protein during the retrograde reaction in mesolimbic dopaminergic neurons. Brain Res 149:141-153.
25. Goto S, Hirano A. 1991. Catecholaminergic neurons in the parabrachial nucleus of normal individuals and patients with idiopathic Parkinson's disease. Ann Neurol 30:192-196.
26. Graeber MB, Tetzlaff W, Streit WJ, Kreutzberg GW. 1988. Microglial cells but not astrocytes undergo mitosis following rat facial nerve axotomy. Neurosci Lett 85:317-321.
27. Greenamyre JT, MacKenzie G, Peng TI, Stephans SE. 1999. Mitochondrial dysfunction in Parkinson's disease. Biochem Soc Symp 66:85-97.
28. Hallman H, Lange J, Olson L, Stromberg I, Jonsson G. 1985. Neurochemical and histochemical characterization of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse. J Neurochem 44:117-127.
29. Heppner FL, Skutella T, Hailer NP, Haas D, Nitsch R. 1998. Activated microglial cells migrate towards sites of excitotoxic neuronal injury inside organotypic hippocampal slice cultures. Eur J Neurosci 10:3284-3290.
30. Hirsch E, Graybiel AM, Agid YA. 1988. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334:345-348.
31. Jonsson G, Sundstrom E, Mefford I, Olson L, Johnson S, Freedman R, Hoffer B. 1985. Electrophysiological and neurochemical correlates of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse. Naunyn-Schmiedebergs Arch Pharmacol 331:1-6.
32. Kaur C, Ling EA. 1992. Activation and re-expression of surface antigen in microglia following an epidural application of kainic acid in the rat brain. J Anat 180:333-342.
33. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS. 2000. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20:6309-6316.
34. Knott C, Stern G, Wilkin GP. 2000. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci 16:724-739.
35. Knusel B, Beck KD, Winslow JW, Rosenthal A, Burton LE, Widmer HR, Nikolics K, Hefti F. 1992. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic neurons but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 12:4391-4402.
36. Kohutnicka M, Lewandowska E, Kurkowska-Jastrzebska I, Czlonkowski A, Czlonkowska A. 1998. Microglial and astrocytic involvement in Parkinson's disease mice model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunophannacology 39:167-180.
37. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
38. Kurkowska-Jastrzebska I, Wroska A, Kohutnicka M, Czlonkowski A, Czlonkowska A. 1999. The inflammatory reaction following 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine intoxication in mouse. Exp Neurol 156:50-61.
39. Lawson LJ, Perry VH, Dri P, Gordon S. 1990. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151-170.
40. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. 1993. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 150:2659-2667.
41. Ling Z, Gayle DA, Ma SY, Lipton JW, Tong CW, Hong JS, Carvey PM. 2002. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord 17:116-124.
42. Liu B, Hong JS. 2003. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304:1-7.
43. Marella M, Chabry J. 2004. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J Neurosci 24:620-627.
44. Matsuoka Y, Kitamura Y, Takahashi H, Tooyama I, Kimura H, Gebicke-Haerter PJ, Nomura Y, Taniguchi T. 1999. Interferon-gamma plus lipopolysaccharide induction of delayed neuronal apoptosis in rat hippocampus. Neurochem Int 34:91-99.
45. McGeer PL, Eccles SJ, McGeer EG. 1987. Molecular neurobiology of the mammalian brain. New York: Plenum.
46. McGeer PL, Itagaki S, Boyes BE, McGeer EG. 1988. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285-1291.
47. Mirza B, Hadberg H, Thomsen P, Moos T. 2000. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience 95:425-432.
48. Mitchell IJ, Cross AJ, Sambrook MA, Crossman AR. 1985. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the macaque monkey include the ventral tegmental area and the locus coeruleus. Neurosci Lett 61:195-200.
49. Mor G, Nilsen J, Horvath T, Bechmann I, Brown S, Garcia-Segura LM, Naftolin F. 1999. Estrogen and microglia: a regulatory system that affects the brain. J Neurobiol 40:484-496.
50. O'Callaghan JP, Miller DB, Reinhard JF Jr. 1990. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Res 521:73-80.
51. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. San Diego CA: Academic Press.
52. Perry VH, Gordon S. 1991. Macrophages and the nervous system. Int Rev Cytol 125:203-244.
53. Ravichandran KS. 2003. "Recruitment signals" from apoptotic cells: invitation to a quiet meal. Cell 113:817-820.
54. Reis DJ, Ross RA. 1973. Dynamic changes in brain dopamine-β- hydroxylase activity during anterograde and retrograde reactions to injury of central noradrenergic axons. Brain Res 57:307-326.
55. Reis DJ, Gilad G, Pickel VM, Joh TH. 1978. Reversible changes in the activities and amounts of tyrosine hydroxylase in dopamine neurons of the substantia nigra in response to axonal injury as studied by immunochemical and immunocytochemical methods. Brain Res 144:325-342.
56. Revuelta M, Venero JL, Machado A, Cano J. 1999. Serotonin hyperinnervation in the adult rat ventral mesencephalon following unilateral transection of the medial forebrain bundle. Correlation with reactive microglial and astroglial populations. Neuroscience 91:567-577.
57. Rinaman L, Milligan CE, Levitt P. 1991. Persistence of fluoro-gold following degeneration of labeled motoneurons is due to phagocytosis by microglia and macrophages. Neuroscience 44:765-776.
58. Rogove AD, Tsirka SE. 1998. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr Biol 8:19-25.
59. Ross RA, Joh TH, Reis DJ. 1975. Reversible changes in the accumulation and activities of tyrosine hydroxylase and dopamine-β-hydroxylase in neurons of nucleus locus ceruleus during the retrograde reaction. Brain Res 92:57-72.
60. Schiefer J, Kampe K, Dodt HU, Zieglgansberger W, Kreutzberg GW. 1999. Microglial motility in the rat facial nucleus following peripheral axotomy. J Neurocytol 28:439-453.
61. Schlegel RA, Williamson P. 2001. Phosphatidylserine, a death knell. Cell Death Differ 8:551-563.
62. Schwab JM, Frei E, Klusman I, Schnell L, Schwab ME, Schluesener HJ. 2001. AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats. J Neuroimmunol 119:214-222.
63. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci USA 88:7438-7442.
64. Seniuk NA, Tatton WG, Greenwood CE. 1990. Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP. Brain Res 527:7-20.
65. Song DY, Park JC, Park BG, Lee JS, Choi BY, Yang YC, Kang HS, Cho BP. 2004. Neuroglial proliferative activity following medial forebrain bundle axotomy. Korean J Anat 37:329-336.
66. Stence N, Waite M, Dailey ME. 2001. Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia 33:256-266.
67. Streit WJ, Kreutzberg GW. 1988. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 268:248-263.
68. Sugama S, Cho BP, DeGiorgio LA, Shimizu Y, Kim SS, Kim YS, Shin DH, Volpe BT, Reis DJ, Cho S, Joh TH. 2003. Temporal and sequential analysis of microglia in the substantia nigra following medial forebrain bundle axotomy in rat. Neuroscience 116:925-933.
69. Takeuchi A, Isobe KI, Miyaishi O, Sawada M, Fan ZH, Nakashima I, Kiuchi K. 1998. Microglial NO induces delayed neuronal death following acute injury in the striatum. Eur J Neurosci 10:1613-1620.
70. Torack RM, Morris JC. 1992. Tyrosine hydroxylase-like (TH) immunoreactivity in Parkinson's disease and Alzheimer's disease. J Neural Transm Park Dis Dement Sect 4:165-171.
71. Uhl GR, Hedreen JC, Price DL. 1985. Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions. Neurology 35:1215-1218.
72. Venero JL, Revuelta M, Cano J, Machado A. 1997. Time course changes in the dopaminergic nigrostriatal system following transection of the medial forebrain bundle: deletion of oxidatively modified proteins in substantia nigra. J Neurochem 68:2458-2468.
73. Wolters EC. 2001. Intrinsic and extrinsic psychosis in Parkinson's disease. J Neurol 248(Suppl 3):III22-27.
74. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771.